Keywords: sanofi, stops, marketing, teva, copaxone, usa, french

Sanofi stops marketing Teva's Copaxone in USA

Article | 07 April 2008

Print This

French drug major Sanofi-Aventis has stopped marketing Copaxone (glatiramer), a drug for the treatment of multiple sclerosis, in the USA. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in